Similar articles

• Serum thymidine kinase in AIDS patients treated with zidovudine.

  Pedersen C, Ingeberg S. Pedersen C, et al. Lancet. 1987 Aug 22;2(8556):460. doi: 10.1016/s0140-6736(87)91002-6. Lancet. 1987. PMID: 2887768 No abstract available.
• Wernicke's encephalopathy in AIDS patient treated with zidovudine.

  Davtyan DG, Vinters HV. Davtyan DG, et al. Lancet. 1987 Apr 18;1(8538):919-20. doi: 10.1016/s0140-6736(87)92892-3. Lancet. 1987. PMID: 2882316 No abstract available.
• Increased frequency of haemarthroses in haemophilic patient treated with zidovudine.

  Ragni MV, Tama G, Lewis JH, Ho M. Ragni MV, et al. Lancet. 1988 Jun 25;1(8600):1454-5. doi: 10.1016/s0140-6736(88)92259-3. Lancet. 1988. PMID: 2898601 No abstract available.
• AIDS commentary. Azidothymidine.

  Hirsch MS. Hirsch MS. J Infect Dis. 1988 Mar;157(3):427-31. doi: 10.1093/infdis/157.3.427. J Infect Dis. 1988. PMID: 3278063 Review. No abstract available.
• From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.

  Curran A, Ribera E. Curran A, et al. Expert Opin Drug Saf. 2011 May;10(3):389-406. doi: 10.1517/14740338.2011.542145. Epub 2011 Jan 17. Expert Opin Drug Saf. 2011. PMID: 21235431 Review.